Focus on monitoring the release of drug catalog, involving 14 varieties of traditional Chinese medicine!

[industry trends of pharmaceutical network] on August 6, the medical administration and medical management office of the health and Health Committee of Tibet Autonomous Region issued a notice, announcing the list of key monitored drugs in Tibet Autonomous Region A total of 34 drugs were included in the catalogue, including 20 chemical and biological products and 14 traditional Chinese medicines According to the announcement, the purpose of adding the catalogue of key monitoring drugs is to improve the relevant work of key monitoring drugs and ensure the rational use of drugs in clinical practice In fact, on July 1 this year, the health administration of the state health and Health Commission issued a notice on printing and distributing a batch of national key monitoring and rational use of drugs (chemical and biological products), involving 20 chemical and biological products According to the requirements of the national health and Health Commission, each provincial health administration department, together with the competent Chinese medicine department, shall, on the basis of the catalogue, form and publish the catalogue of drugs for key monitoring and rational use at the provincial level, which shall be reported to the national health and Health Commission and the State Administration of traditional Chinese medicine for filing It can also be seen from the announcement that 14 varieties of traditional Chinese medicine have been added to the list of key monitoring drugs published in Tibet on the basis of the national version At present, in addition to Tibet, Inner Mongolia, Qingdao, Weihai and other places have also issued relevant documents to limit the varieties of traditional Chinese medicine and promote rational use of drugs Inner Mongolia issued a request to stop 55 auxiliary drugs, half of which are traditional Chinese medicine Most of them are injections, including salvianolic acid, safflower yellow pigment, Xueshuantong, Xuesaitong, Xiyanping, Xuebijing, etc
In the implementation opinions on Further Strengthening the management of clinical rational drug use issued by Qingdao, the interim catalogue of key monitored drugs in hospitals, the catalogue of traditional Chinese medicine injection drugs in hospitals and the quota of the total amount of monthly use of key monitored drugs in each department were published, and the quota of drug proportion, key monitored drugs, decoction pieces of traditional Chinese medicine and prescription authority management of Chinese patent medicine were detailed Details Among them, there are 36 drugs in the provisional list of key monitoring drugs, not only involving 17 national version of key monitoring directory varieties, but also including Xuesaitong, Xueshuantong, safflower yellow pigment and other traditional Chinese medicine injections In the second batch of 85 kinds of drugs under condition monitoring issued by Weihai, there are 85 varieties in total, including 41 injections and 44 traditional Chinese medicine preparations Traditional Chinese medicine preparations include Reduning injection, Tanreqing injection, Shenfu injection, Chuankezhi injection, Huangqi injection, Shengmai injection, Shenmai injection and other products In addition to the above local issued documents limiting the varieties of traditional Chinese medicine, since 2018, the information about the revision of the manual of traditional Chinese medicine injections has also been coming, including many large varieties In fact, it also reflects from the side that the traditional Chinese medicine injection industry is facing a big reshuffle, and the relevant production enterprises may be affected But from the point of view of purpose, its main purpose is to ensure the safety of drugs, standardize the rational use of drugs, eliminate some of the safety risks brought by drugs whose safety has not been confirmed or whose reliability is questionable, and protect the rights and interests of drug patients The industry said that the development of traditional Chinese medicine industry has risen to the national strategy, which means ushering in a good era of development However, for traditional Chinese medicine injection, it is still necessary to consider the safety and reliability, use scientific facts and data to prove the clinical target, effectiveness and safety of products, and cultivate large varieties of traditional Chinese medicine with high scientific value, clinical value and market value.